Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study

来那度胺 医学 美罗华 弥漫性大B细胞淋巴瘤 伊布替尼 内科学 临床终点 临床研究阶段 肿瘤科 淋巴瘤 胃肠病学 外科 临床试验 多发性骨髓瘤 慢性淋巴细胞白血病 白血病
作者
Pengpeng Xu,Zi‐Yang Shi,Ying Qian,Shu Cheng,Yue Zhu,Lu Jiang,Jianfeng Li,Hai Fang,Hengye Huang,Hongmei Yi,Bin-Sheng Ouyang,Li Wang,Weili Zhao
出处
期刊:The Lancet Healthy Longevity [Elsevier BV]
卷期号:3 (7): e481-e490 被引量:27
标识
DOI:10.1016/s2666-7568(22)00123-4
摘要

The optimal treatment for older adults with diffuse large B-cell lymphoma (DLBCL) needs to be further explored due to patient comorbidities, standard immunochemotherapy intolerance, and unfavourable genetic features. We did a phase 2 trial of ibrutinib, rituximab, and lenalidomide (iR2) to evaluate the efficacy and safety in older adult patients with de novo DLBCL.In this phase 2, single-arm study, unfit or frail patients with de novo DLBCL aged 75 years or older were enrolled at Shanghai Ruijin Hospital, Shanghai, China. During the induction phase from cycle 1 to 6, 560 mg ibrutinib was given orally daily throughout each 21-day treatment cycle, 375 mg/m2 rituximab was given intravenously on day 1, and 25 mg lenalidomide was given orally daily from day 1 to 10 in each cycle. Patients who had a complete response after induction were given another 6 cycles of lenalidomide maintenance (25 mg orally daily from day 1 to 10 every 21 days from cycle 7 to 12). The primary endpoint was complete response rate after 6 cycles or at the end of the induction treatment. This trial is registered with ClinicalTrials.gov, NCT03949062.Between May 15, 2019, and May 8, 2020, a total of 30 patients were enrolled. The end of induction complete response rate was 56·7% (95% CI 37·4-74·5), and overall response rate was 66·7% (95% CI 47·2-82·7). With a median follow-up of 27·6 months (IQR 23·9-29·6), the 2-year progression-free survival rate was 53·3% (95% CI 34·3-69·1) and the 2-year overall survival rate was 66·7% (95% CI 46·9-80·5). The main grade 3-4 haematological adverse events were neutropenia (seven patients [23%]), thrombocytopenia (three patients [10%]), and anaemia (two patients [7%]). The most common grade 3-4 non-haematological adverse event was pulmonary infection (seven patients [23%]). Atrial fibrillation was observed in three (10%) patients, including one grade 2 and two grade 3.A chemotherapy-free iR2 regimen is clinically effective and safe and warrants further investigation in phase 3 trials as first-line treatment in older adult patients with DLBCL.National Natural Science Foundation of China, Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant Support, Clinical Research Plan of Shanghai Hospital Development Center, and Multicenter Clinical Research Project by Shanghai Jiao Tong University School of Medicine.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
研友_Z3342Z完成签到,获得积分10
2秒前
xrkxrk完成签到 ,获得积分0
3秒前
yiyiyi完成签到,获得积分10
3秒前
坚强成风完成签到,获得积分10
4秒前
8秒前
10秒前
11秒前
12秒前
Polarlicht完成签到,获得积分10
13秒前
媛媛完成签到,获得积分10
13秒前
傲娇颖完成签到,获得积分10
15秒前
ShellyMaya完成签到 ,获得积分10
16秒前
17秒前
一只大憨憨猫完成签到,获得积分10
17秒前
JJ完成签到,获得积分10
17秒前
DrW完成签到,获得积分10
17秒前
隐形曼青应助yue采纳,获得10
18秒前
ccyy完成签到 ,获得积分10
18秒前
NexusExplorer应助腾腾腾采纳,获得10
19秒前
宿帅帅完成签到,获得积分10
20秒前
20秒前
Ningxin完成签到,获得积分10
20秒前
HHEHK发布了新的文献求助10
20秒前
柚子完成签到 ,获得积分10
20秒前
雨辰完成签到,获得积分10
22秒前
宿帅帅发布了新的文献求助10
22秒前
量子星尘发布了新的文献求助10
25秒前
25秒前
熠熠完成签到,获得积分10
25秒前
26秒前
zxzb完成签到,获得积分10
28秒前
苹果萧完成签到 ,获得积分10
31秒前
宋江他大表哥完成签到,获得积分10
31秒前
able发布了新的文献求助10
31秒前
王先生完成签到 ,获得积分10
32秒前
H.发布了新的文献求助10
32秒前
luoluo完成签到,获得积分10
33秒前
33秒前
高分子完成签到,获得积分10
33秒前
yian发布了新的文献求助10
34秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038303
求助须知:如何正确求助?哪些是违规求助? 3576013
关于积分的说明 11374210
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029